LifeStance Health reports new anxiety medications are expected for 2026, featuring innovative treatments in clinical trials ...

Shandong Quanzhong Biomedical Technology Co. Ltd. has synthesized monoamine transmitter reuptake inhibitors reported to be useful for the treatment of neurological disorders, depression, autism, pain, ...